Globe Newswire News Releases

May 08, 2024 07:50 ET
Presenting on the Emerging Growth Conference 70 Day 2 on May 9 Register Now
EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 70th Emerging Growth Conference on May 8 & 9, 2024. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong...
May 08, 2024 07:45 ET
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of agilon health
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against agilon health, inc. (“agilon” or the “Company”) (NYSE: AGL) and reminds investors of the May 20, 2024 deadline to seek the role of lead...
May 08, 2024 07:45 ET
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Shoals
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Shoals Technologies Group, Inc. (“Shoals” or the “Company”) (NASDAQ: SHLS) and reminds investors of the May 21, 2024 deadline to seek the role...
May 08, 2024 07:45 ET
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of SSR Mining
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against SSR Mining Inc. (“SSR Mining” or the “Company”) (NASDAQ: SSRM) and reminds investors of the May 17, 2024 deadline to seek the role of lead...
May 08, 2024 07:45 ET
IntelGenx Announces Voting Results on Election of Directors
IntelGenx Technologies Corp. (TSX: IGX) (OTCQB: IGXT) (the “Company” or “IntelGenx”) announces that, at the annual meeting of shareholders of the Company held on May 7, 2024 (the “Annual Meeting”), shareholders voted in favour of all items of...
May 08, 2024 07:45 ET
Treos Bio to Present New Clinical Data on Off-the-Shelf Peptide Immunotherapy for Colorectal Cancer at 2024 ASCO Annual Meeting
Treos Bio, a clinical stage biotechnology company using data science and proprietary biomarkers to develop precision peptide immunotherapies, said investigators will present new results from a phase 2 trial of the company’s lead product candidate...
May 08, 2024 07:40 ET
Vigil Neuroscience to Present at The Citizens JMP Life Sciences Conference
Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative diseases, today announced that management will participate in a fireside chat at...
May 08, 2024 07:30 ET
MasterCraft Boat Holdings, Inc. Reports Results for Fiscal 2024 Third Quarter
MasterCraft Boat Holdings, Inc. (NASDAQ: MCFT) today announced financial results for its fiscal 2024 third quarter ended March 31, 2024. The overview, commentary, and results provided herein relate to our continuing operations. Overview: Net...
May 08, 2024 07:30 ET
Kornit Digital Reports First Quarter 2024 Results
Kornit Digital Ltd. (“Kornit” or the “Company”) (Nasdaq: KRNT), a worldwide market leader in sustainable, on-demand, digital fashionX and textile production technologies, reported today its results for the first quarter ended March 31, 2024....
May 08, 2024 07:30 ET
Amerigo Announces Q1-2024 Results & Quarterly Dividend
Amerigo Resources Ltd. (TSX: ARG; OTCQX: ARREF) (“Amerigo” or the “Company”) is pleased to announce financial results for the three months ended March 31, 2024 (“Q1-2024”). Dollar amounts in this news release are in U.S. dollars unless indicated...
May 08, 2024 07:30 ET
BioRestorative Therapies Enhances Preclinical Metabolic Program with a Novel Exosome-Based Biologic Targeting Obesity
BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage company focused on stem cell-based therapies, today announced its development of a novel exosome-based biologic program targeting obesity....
May 08, 2024 07:30 ET
BrainsWay Reports First Quarter 2024 Financial Results and Operational Highlights
BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a world leader in advanced and non-invasive treatment for brain disorders, today reported first quarter 2024 financial results and provided an operational update. Recent...
May 08, 2024 07:30 ET
Cytokinetics Announces Start of CEDAR-HCM, a Clinical Trial of Aficamten in a Pediatric Population With Symptomatic Obstructive Hypertrophic Cardiomyopathy
Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that CEDAR-HCM (Clinical Evaluation of Dosing with Aficamten to Reduce Obstruction in a Pediatric Population in HCM), a clinical trial of aficamten in a pediatric population with symptomatic...
May 08, 2024 07:30 ET
Cytokinetics Announces Topline Data From Phase 1 Clinical Study of CK-4021586
Cytokinetics, Incorporated (Nasdaq: CYTK) today announced topline data from the Phase 1 study of CK-4021586 (CK-586). The study met its primary and secondary objectives to assess the safety, tolerability and pharmacokinetics (PK) of single and...
May 08, 2024 07:30 ET
Else Nutrition Expands Product Listings at Major U.S. Food Retailer
ELSE NUTRITION HOLDINGS INC. (BABY) (BABYF) (0YL.F) ("Else" or the "Company"), is proud to announce that it has expanded its product listings at one of the largest independent food retailers in the United States, which ranks 5th among the largest...
May 08, 2024 07:30 ET
FitLife Brands Announces First Quarter Earnings Call and its Participation at Sidoti Virtual Investor Conference and Provides Operational Update
FitLife Brands, Inc. (“FitLife,” or the “Company”) (Nasdaq: FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced that it will participate in the Sidoti Virtual Investor Conference on...
May 08, 2024 07:30 ET
Genie Energy Announces First Quarter 2024 Results
Genie Energy, Ltd. (NYSE: GNE), a leading retail energy and renewable energy solutions provider, today announced results for the first quarter of 2024.  Michael Stein, chief executive officer of Genie Energy, commented:...
May 08, 2024 07:30 ET
HPQ Silicon Signs MOU With Impact Funding Europe for Collaboration on EU Funding Programs
HPQ Silicon Inc. (“HPQ” or the “Company”) (TSX-V: HPQ) (OTCQB: HPQFF) (FRA: O08), a technology company specializing in green engineering of silica and silicon-based materials, announces the signing of a Memorandum of Understanding (MOU) with Impact...
May 08, 2024 07:30 ET
InflaRx Reports First Quarter 2024 Financial Results and Provides Business Update
InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, today announced financial results for the three months ended March 31, 2024, and provided an operating update....
May 08, 2024 07:30 ET
Kelly to Participate in the 18th Annual Barrington Research Virtual Spring Investment Conference
Kelly (Nasdaq: KELYA, KELYB), a leading global specialty talent solutions provider, today announced it will participate in the 18th Annual Barrington Research Virtual Spring Investment Conference on Thursday, May 16, 2024. Peter Quigley,...